National NIH K12 DiabDocs Program (DiabDocs Program)

The DiabDocs program is now soliciting a fourth cycle of letters of intent for applications for our mentored career development program from early career physician scientists engaged in research relevant to diabetes and within the scope of NIDDK including basic, translational, clinical, epidemiology/biostatistical, informatics, health services or health policy projects. Most funded scholars will focus on type 1 diabetes (T1D) research, and limited slots are available for persons working in type 2 diabetes (T2D).

Letter of Intent Due Date: November 12, 2024
Application Due Date: January 13, 2025

dkNET Pilot Funding Program in AI Models to Accelerate Diabetes Heterogeneity Research (2024 dkNET AI Pilot Funding Program )

One major challenge in Type 2 Diabetes (T2D) is the enormous heterogeneity associated with the disease. This pilot funding program, through the NIDDK Information Network (dkNET), is designed to capitalize on the rapid advances in AI and other data science areas in addressing major gaps in the study of Type 2 Diabetes (T2D) heterogeneity, including opportunities in extracting knowledge from the enormous amount of data and literature, and in recruiting AI experts to this area of domain science. It calls for multi-disciplinary teams to: 1) develop AI foundation models for T2D; (2) validate the models with top research questions in T2D heterogeneity; (3) disseminate the models and engage the community for further development, validation and application; and (4) develop use cases that demonstrate the models’ potential in accelerating research in diabetes heterogeneity study. The teams are expected to work with dkNET to coordinate their projects, so that awardees can integrate and share products through the dkNET platform.

Letter of Intent Due Date: October 11, 2024
Application Due Date: November 12, 2024

Notice of NIDDK’s Participation in PAR-23-237 -Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed) (PAR-23-237)

The purpose of this notice is to inform potential applicants that the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) will participate, effective immediately in PAR-23-237, Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed).

Application due date: January 26, 2025 

Follow
×

Follow

us on our social networks.